International Psoriasis Council
Advancing Knowledge. Improving Care.
The IPC Virtual Psoriasis Masterclass is designed for early career dermatologists who are making treatment decisions and managing patients with psoriasis and are interested in specializing in psoriasis.
Over the five weekly two-hour sessions of the course, IPC’s world-renowned experts will cover various topics, including the pathogenesis of psoriasis, new and emerging therapies, and how to advocate for your patient.
The Masterclass agenda has been carefully developed to provide knowledge for daily use to the practicing dermatologist in an intimate environment designed to maximize faculty/participant interactions. Through lectures, panels, case-based discussions and question-answer sessions, attendees will obtain practical and important information for their clinical practice.
The IPC Masterclass is open to dermatologists who meet the following criteria:
WELCOME + INTRODUCTION
André Carvalho
Pathophysiology and Genetic
Margarita Velásquez
Clinical Manifestations of Psoriasis
Peter van de Kerkhof
Psoriasis in Special Areas
Cristina Echeverría
Clinical Cases
Fellows as Panelists
CLOSING COMMENTS
Angela Londoño
WELCOME + INTRODUCTION
Angela Londoño
Overview of Psoriasis Comorbidities
Álvaro González-Cantero
Psoriatic Arthritis for Dermatologists
Joseph Merola
Generalized Pustular Psoriasis
Ricardo Romiti
Pediatric Psoriasis
Enrique Rivas
Clinical Cases
Fellows as Panelists
CLOSING COMMENTS
Romina Contreras
WELCOME + INTRODUCTION
Romina Contreras
Treat to Target, Minimal Disease Activity, Early Intervention
Ron Vender
Topical Therapies and Phototherapy
Benjamin Hidalgo
Methotrexate
Matías Maskin
Clinical Cases
Fellows as Panelists
CLOSING COMMENTS
André Carvalho
WELCOME + INTRODUCTION
André Carvalho
Screening and Monitorization of Biologics
Tiago Torres
Anti TNF-a
Romina Contreras
Anti IL 17
César Gonzalez
Anti IL12/23 and Anti IL-23
Paolo Gisondi
New Oral Therapies
Fernando Valenzuela
CLOSING COMMENTS
Angela Londoño
WELCOME + INTRODUCTION
André Carvalho
My Challenging Cases
Wayne Gulliver & Claudia de la Cruz
Clinical Cases
Q & A Session
All faculty
KEY LEARNING AND CLOSING COMMENTS
All co-chair
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.
